Australia Medical Cannabis Market, by Application

Growth Outlook

• The Australia Medical Cannabis Market, by Application market is on a steady long-term growth path. Segment value stands at roughly USD 1220 Mn in 2026 and is projected to reach USD 1471 Mn by 2027 — a gain of about 21% over the forecast period, translating to a CAGR in the double digits.
• What the regional split looks like (2026): Pain Management leads, holding roughly 46% of segment value — the single largest regional share. Neurological Health Management is the second-largest contributor. Mental Health Management make up the remainder, in descending order.
• By 2027, Pain Management alone is expected to reach USD 675 Mn, with Neurological Health Management at USD 501 Mn.

Market Dynamics

The demand for medical cannabis in Australia has been on the rise in recent years, due to its potential benefits in treating various medical conditions. While the use of cannabis for medicinal purposes has been legalized in Australia since 2016, it has gained significant traction only in the past few years. This can be attributed to the increasing awareness and acceptance of cannabis as a potential alternative treatment option, as well as the growing number of clinical trials and studies showcasing the effectiveness of medical cannabis.

One of the major applications of medical cannabis in Australia is for chronic pain management. Chronic pain is a prevalent condition in Australia, with approximately 1 in 5 Australians suffering from it. Traditional pain medications have been effective in managing pain for some individuals, but for others, they may lead to severe side effects or simply not be effective. This has led many to turn to medical cannabis as an alternative treatment option. Studies have shown that medical cannabis may be effective in managing chronic pain, especially in conditions like multiple sclerosis, cancer, and neuropathic pain.

Another significant application of medical cannabis in Australia is for mental health conditions. Mental health issues, such as anxiety, depression, and post-traumatic stress disorder (PTSD), are becoming increasingly common in Australia. Traditional treatments for these conditions, such as antidepressants and anti-anxiety medications, may have problematic side effects and may not work for everyone. Medical cannabis has shown promising results in managing these conditions, as it can potentially reduce anxiety and improve mood.

Epilepsy is another condition that has seen a rise in demand for medical cannabis in Australia. Epilepsy is a neurological disorder characterized by recurrent seizures, affecting approximately 250,000 Australians. Traditional anti-seizure medications are not always effective, and in some cases, may have severe side effects. Several studies have shown that medical cannabis may be effective in reducing the frequency and severity of seizures in patients with epilepsy.

In addition to these applications, medical cannabis is also being researched for its potential uses in conditions such as cancer, HIV/AIDS, Crohn's disease, and Parkinson's disease. As more evidence of its benefits emerges, the demand for medical cannabis in these and other applications is expected to increase in Australia.

In conclusion, the demand for medical cannabis in Australia is being driven by the potential to treat a wide range of medical conditions for which traditional treatments may not be effective or may have severe side effects. With increasing awareness and acceptance, coupled with ongoing research, the demand for medical cannabis in Australia is poised to continue growing in the coming years.